FDA Website Confirms Cyberonics' Depression Panel Date
27 April 2004 - 6:51AM
PR Newswire (US)
FDA Website Confirms Cyberonics' Depression Panel Date HOUSTON,
April 26 /PRNewswire-FirstCall/ -- Cyberonics, Inc. today announced
that FDA confirmed on its website
(http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfadvisory/details.cfm?mtg=
512 ) that a meeting of its Neurological Devices Advisory Panel
will occur on June 15, 2004 to review Cyberonics' PMA-Supplement
(PMA-S) seeking approval to market the VNS Therapy(TM) System "as
an adjunctive long-term treatment of chronic or recurrent
depression for patients over the age of 18 who are experiencing a
major depressive episode that has not had an adequate response to
two or more adequate antidepressant treatments." DATASOURCE:
Cyberonics, Inc. CONTACT: Pamela Westbrook, Vice President of
Finance and CFO of Cyberonics, Inc., +1-281-228-7200, or fax,
+1-281-218-9332, or ; or Helen Shik, Vice President of Schwartz
Communications, +1-781-684-0770, ext. 6587, or fax,
+1-781-684-6500, or , for Cyberonics, Inc. Web site:
http://www.cyberonics.com/
Copyright